Automated Cell Counter Market Report 2026

Automated Cell Counter Market Overview

• Automated Cell Counter market size has reached to $5.75 billion in 2025 • Expected to grow to $7.68 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Rising Adoption Of Personalized Medicine Expected To Drive Growth In Automated Cell Counter Market • Market Trend: AI-Powered Cell Culture Systems Revolutionize Lab Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Automated Cell Counter Market?

An automated cell counter refers to a specialized instrument used in laboratory settings to count cells rapidly and accurately within a biological sample. These instruments utilize advanced optical or electronic technologies to automate the cell counting process, eliminating the need for manual counting under a microscope. The main types of products in an automated cell counter are consumable accessories and instruments. Consumables and accessories in the automated cell counting include items such as reagents, calibration standards, and disposable slides or microplates, essential for conducting cell counting procedures accurately and efficiently. The products are used in applications such as blood analysis, urine analysis, microbial cell count, cell line viability, and others. The end users are pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, research institutes, and others.

What Is The Automated Cell Counter Market Growth Forecast?

The automated cell counter market size is expected to see strong growth in the next few years. It will grow to $7.68 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growth in personalized medicine research, increasing automation in clinical laboratories, rising adoption of point of care diagnostics, advancements in cell based assays, expansion of biotech research facilities. Major trends in the forecast period include increasing adoption of automated cell counters in clinical diagnostics, rising demand for high throughput cell analysis in research labs, growing preference for optical based automated cell counting systems, expansion of automated cell counters in biopharmaceutical r&d, rising integration of automated cell counting in routine laboratory workflows.

What Is The Driver Of The Automated Cell Counter Market?

The rising adoption of personalized medicine is expected to propel the growth of the automated cell counter market going forward. Personalized medicine refers to tailoring medical treatment to each patient's individual characteristics, often based on genetic, environmental, and lifestyle factors. Personalized medicine applications are rising due to advancements in genetic research and technology, enabling more precise and effective treatments tailored to individual patient's unique genetic profiles and health data. Automated cell counting is utilized in personalized medicine to analyze patient-specific cell populations rapidly and accurately, aiding in the customization of treatments based on individual cellular profiles. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based hospital and healthcare company, the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from the 6 approved in 2022. Therefore, the rising adoption of personalized medicine will drive the growth of the automated cell counter industry.

Key Players In The Global Automated Cell Counter Market

Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd, Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc, Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.

Global Automated Cell Counter Market Trends and Insights

Major companies operating in the automated cell counter market are focusing on the integration of intelligence algorithms and machine learning, such as the AI automated cell culture system, to optimize and automate the process of cell growth and scalability in biological research and biomanufacturing. An AI-automated cell culture system is a technology that utilizes artificial intelligence to autonomously monitor, manage, and optimize cell growth and maintenance in laboratory settings. For instance, in October 2023, Molecular Devices LLC, a U.S.-based supplier of analytical systems, introduced the CellXpress.AI automated cell culture system, an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab. The hub incorporates cutting-edge technology designed to seamlessly oversee the entire cell journey. It boasts advanced machine learning-powered software that simplifies the navigation and supervision of complex cell culture processes, complete with pre-programmed protocols for generating both 2D and 3D models.

What Are Latest Mergers And Acquisitions In The Automated Cell Counter Market?

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. The aim of this acquisition is to enhance Cell Microsystems capabilities in cellular analysis by integrating Fluxion Biosciences' advanced patch clamp technology and assay tools. Fluxion Biosciences is a US-based biotechnology company that specializes in developing automated systems and tools for cell-based assays and electrophysiology.

What Defines the Automated Cell Counter Market?

The automated cell counter market consists of revenues earned by entities by providing services such as instrument installation, maintenance, technical support, training programs, cell counting processes and customization options. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated cell counter market also includes sales of flow cytometers, image-based cell counters, electrical impedance Coulter counters, reagents, calibration standards, and disposable slides or microplates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Automated Cell Counter Market Report 2026?

The automated cell counter market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the automated cell counter industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.